# PeptideScanner evidence objects: Survodutide

Every published version of the records placed with Survodutide, one section per evidence object. The section anchor is the object's path id; the JSON twin is https://peptidescanner.com/evidence/v1/peptides/survodutide.json. Selected public evidence only; not medical advice.

- Objects: 21
- Manifest: https://peptidescanner.com/evidence/v1/manifest.json

---

<a id="clinicaltrials-gov-nct06077864-survodutide-v1"></a>

## ClinicalTrials.gov record NCT06077864

> PeptideScanner retained ClinicalTrials.gov record NCT06077864 at 2026-08-13T05:52:27.018Z. Its registry update date was 2026-08-11, and PeptideScanner's reviewed identity mapping was survodutide.

- Evidence object: `story:clinicaltrials-gov-nct06077864-survodutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-08-11
- Source checked: 2026-08-13
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06077864-survodutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct06077864-survodutide-v1
- Content SHA-256: `fb1a622e7f611bdbf526f3a557483237ec6b86e91cb7720f7371a15ffeff64d4`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT06077864 ([`ctg-observation-nct06077864-2026-08-11-60e24ca2b385`](#source-ctg-observation-nct06077864-2026-08-11-60e24ca2b385))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06077864 at 2026-08-13T05:52:27.018Z. Its registry update date was 2026-08-11, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct06077864-2026-08-11-60e24ca2b385`](#source-ctg-observation-nct06077864-2026-08-11-60e24ca2b385))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06077864 at 2026-08-13T05:52:27.018Z. Its registry update date was 2026-08-11, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct06077864-2026-08-11-60e24ca2b385`](#source-ctg-observation-nct06077864-2026-08-11-60e24ca2b385))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06077864-2026-08-11-60e24ca2b385`](#source-ctg-observation-nct06077864-2026-08-11-60e24ca2b385))

### Sources

<a id="source-ctg-observation-nct06077864-2026-08-11-60e24ca2b385"></a>
- **ClinicalTrials.gov record NCT06077864 · retained source version 2026-08-11:60e24ca2b3858aa7bfd06f0e1cac79051207229d8181cdbe15a0399bddf60984** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06077864) (`ctg-observation-nct06077864-2026-08-11-60e24ca2b385`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06077864." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct06077864-survodutide-v1 SHA-256: fb1a622e7f611bdbf526f3a557483237ec6b86e91cb7720f7371a15ffeff64d4.

---

<a id="clinicaltrials-gov-nct06077864-survodutide-v2"></a>

## ClinicalTrials.gov record NCT06077864

> PeptideScanner retained ClinicalTrials.gov record NCT06077864 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was survodutide.

- Evidence object: `story:clinicaltrials-gov-nct06077864-survodutide:v2`
- Evidence domain: Clinical trials
- Date in source: 2026-11-12
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06077864-survodutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct06077864-survodutide-v2
- Content SHA-256: `fd5e20074b98dad3a50dbfa349ad4d74493c8d25893150730f4c19181ba1fe97`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT06077864 ([`ctg-observation-nct06077864-2026-08-11-60e24ca2b385-r2`](#source-ctg-observation-nct06077864-2026-08-11-60e24ca2b385-r2))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06077864 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct06077864-2026-08-11-60e24ca2b385-r2`](#source-ctg-observation-nct06077864-2026-08-11-60e24ca2b385-r2))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06077864 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct06077864-2026-08-11-60e24ca2b385-r2`](#source-ctg-observation-nct06077864-2026-08-11-60e24ca2b385-r2))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06077864-2026-08-11-60e24ca2b385-r2`](#source-ctg-observation-nct06077864-2026-08-11-60e24ca2b385-r2))

### Sources

<a id="source-ctg-observation-nct06077864-2026-08-11-60e24ca2b385-r2"></a>
- **ClinicalTrials.gov record NCT06077864 · retained source version 2026-11-12:c105119130825811c47f700fb470d08d998ed9023b083bdf084894e39b831111** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06077864) (`ctg-observation-nct06077864-2026-08-11-60e24ca2b385-r2`)

### Correction lineage

updated on 2026-11-15: ClinicalTrials.gov posted a newer version of NCT06077864, with a registry update date of 2026-11-12. This version reports that observation; the earlier retained observation remains available as version 1.
- Supersedes version: 1
- Correction sources: [`ctg-observation-nct06077864-2026-08-11-60e24ca2b385-r2`](#source-ctg-observation-nct06077864-2026-08-11-60e24ca2b385-r2)

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06077864." Version 2, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct06077864-survodutide-v2 SHA-256: fd5e20074b98dad3a50dbfa349ad4d74493c8d25893150730f4c19181ba1fe97.

---

<a id="clinicaltrials-gov-nct06176365-survodutide-v1"></a>

## ClinicalTrials.gov record NCT06176365

> PeptideScanner retained ClinicalTrials.gov record NCT06176365 at 2026-07-30T16:20:49.317Z. Its registry update date was 2026-04-30, and PeptideScanner's reviewed identity mapping was survodutide.

- Evidence object: `story:clinicaltrials-gov-nct06176365-survodutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-04-30
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06176365-survodutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct06176365-survodutide-v1
- Content SHA-256: `d0c18c52e9a74391a77afeb7b8946014b6536946a06d0005d46f36fa3d84fbb3`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT06176365 ([`ctg-observation-nct06176365-2026-04-30-4020a2cdb18b`](#source-ctg-observation-nct06176365-2026-04-30-4020a2cdb18b))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06176365 at 2026-07-30T16:20:49.317Z. Its registry update date was 2026-04-30, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct06176365-2026-04-30-4020a2cdb18b`](#source-ctg-observation-nct06176365-2026-04-30-4020a2cdb18b))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06176365 at 2026-07-30T16:20:49.317Z. Its registry update date was 2026-04-30, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct06176365-2026-04-30-4020a2cdb18b`](#source-ctg-observation-nct06176365-2026-04-30-4020a2cdb18b))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06176365-2026-04-30-4020a2cdb18b`](#source-ctg-observation-nct06176365-2026-04-30-4020a2cdb18b))

### Sources

<a id="source-ctg-observation-nct06176365-2026-04-30-4020a2cdb18b"></a>
- **ClinicalTrials.gov record NCT06176365 · retained source version 2026-04-30:4020a2cdb18b2562f2b7cfbe7f2d4b17826e1b529c9b1b71a798c34b676ca77f** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06176365) (`ctg-observation-nct06176365-2026-04-30-4020a2cdb18b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06176365." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct06176365-survodutide-v1 SHA-256: d0c18c52e9a74391a77afeb7b8946014b6536946a06d0005d46f36fa3d84fbb3.

---

<a id="clinicaltrials-gov-nct06309992-survodutide-v1"></a>

## ClinicalTrials.gov record NCT06309992

> PeptideScanner retained ClinicalTrials.gov record NCT06309992 at 2026-07-30T16:20:49.307Z. Its registry update date was 2026-04-30, and PeptideScanner's reviewed identity mapping was survodutide.

- Evidence object: `story:clinicaltrials-gov-nct06309992-survodutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-04-30
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06309992-survodutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct06309992-survodutide-v1
- Content SHA-256: `1131b6a257f9918c616a22f1599936f83c0f74433afe023bf2e4bc15ccb1cd62`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT06309992 ([`ctg-observation-nct06309992-2026-04-30-430b239e5ae7`](#source-ctg-observation-nct06309992-2026-04-30-430b239e5ae7))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06309992 at 2026-07-30T16:20:49.307Z. Its registry update date was 2026-04-30, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct06309992-2026-04-30-430b239e5ae7`](#source-ctg-observation-nct06309992-2026-04-30-430b239e5ae7))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06309992 at 2026-07-30T16:20:49.307Z. Its registry update date was 2026-04-30, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct06309992-2026-04-30-430b239e5ae7`](#source-ctg-observation-nct06309992-2026-04-30-430b239e5ae7))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06309992-2026-04-30-430b239e5ae7`](#source-ctg-observation-nct06309992-2026-04-30-430b239e5ae7))

### Sources

<a id="source-ctg-observation-nct06309992-2026-04-30-430b239e5ae7"></a>
- **ClinicalTrials.gov record NCT06309992 · retained source version 2026-04-30:430b239e5ae7ee98f81c292434099dde0366f23dd438815aecd018aaa77f2255** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06309992) (`ctg-observation-nct06309992-2026-04-30-430b239e5ae7`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06309992." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct06309992-survodutide-v1 SHA-256: 1131b6a257f9918c616a22f1599936f83c0f74433afe023bf2e4bc15ccb1cd62.

---

<a id="clinicaltrials-gov-nct06632444-survodutide-v1"></a>

## ClinicalTrials.gov record NCT06632444

> PeptideScanner retained ClinicalTrials.gov record NCT06632444 at 2026-08-13T05:52:27.024Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was survodutide.

- Evidence object: `story:clinicaltrials-gov-nct06632444-survodutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-08-10
- Source checked: 2026-08-13
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06632444-survodutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct06632444-survodutide-v1
- Content SHA-256: `dab0721722ef8f5b2128c8df76fbd0b95b6db4f203a3a26236955abed779db55`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT06632444 ([`ctg-observation-nct06632444-2026-08-10-1ea3a43e551b`](#source-ctg-observation-nct06632444-2026-08-10-1ea3a43e551b))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06632444 at 2026-08-13T05:52:27.024Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct06632444-2026-08-10-1ea3a43e551b`](#source-ctg-observation-nct06632444-2026-08-10-1ea3a43e551b))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06632444 at 2026-08-13T05:52:27.024Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct06632444-2026-08-10-1ea3a43e551b`](#source-ctg-observation-nct06632444-2026-08-10-1ea3a43e551b))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06632444-2026-08-10-1ea3a43e551b`](#source-ctg-observation-nct06632444-2026-08-10-1ea3a43e551b))

### Sources

<a id="source-ctg-observation-nct06632444-2026-08-10-1ea3a43e551b"></a>
- **ClinicalTrials.gov record NCT06632444 · retained source version 2026-08-10:1ea3a43e551b6ef84f40e37bc415c00395c246a224788f11cf329d28dbe0b087** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06632444) (`ctg-observation-nct06632444-2026-08-10-1ea3a43e551b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06632444." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct06632444-survodutide-v1 SHA-256: dab0721722ef8f5b2128c8df76fbd0b95b6db4f203a3a26236955abed779db55.

---

<a id="clinicaltrials-gov-nct06632457-survodutide-v1"></a>

## ClinicalTrials.gov record NCT06632457

> PeptideScanner retained ClinicalTrials.gov record NCT06632457 at 2026-08-13T05:52:27.009Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was survodutide.

- Evidence object: `story:clinicaltrials-gov-nct06632457-survodutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-08-10
- Source checked: 2026-08-13
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06632457-survodutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct06632457-survodutide-v1
- Content SHA-256: `ddeb2ed8d1c67695ccb9d60f2e396b49459693f87063e9182164cbb75ddc449f`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT06632457 ([`ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad`](#source-ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06632457 at 2026-08-13T05:52:27.009Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad`](#source-ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06632457 at 2026-08-13T05:52:27.009Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad`](#source-ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad`](#source-ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad))

### Sources

<a id="source-ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad"></a>
- **ClinicalTrials.gov record NCT06632457 · retained source version 2026-08-10:3a1f9c84b9ad4d95e83e8684095eae6c48a87b79b202cf635ea43ffea0a56b3f** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06632457) (`ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06632457." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct06632457-survodutide-v1 SHA-256: ddeb2ed8d1c67695ccb9d60f2e396b49459693f87063e9182164cbb75ddc449f.

---

<a id="clinicaltrials-gov-nct06632457-survodutide-v2"></a>

## ClinicalTrials.gov record NCT06632457

> PeptideScanner retained ClinicalTrials.gov record NCT06632457 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was survodutide.

- Evidence object: `story:clinicaltrials-gov-nct06632457-survodutide:v2`
- Evidence domain: Clinical trials
- Date in source: 2026-11-12
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06632457-survodutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct06632457-survodutide-v2
- Content SHA-256: `ad2f928cfdfb3b953dffbae67312dda58b9a51c4dc2c7f3b3ab9ea47b97f6991`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT06632457 ([`ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad-r2`](#source-ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad-r2))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06632457 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad-r2`](#source-ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad-r2))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06632457 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad-r2`](#source-ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad-r2))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad-r2`](#source-ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad-r2))

### Sources

<a id="source-ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad-r2"></a>
- **ClinicalTrials.gov record NCT06632457 · retained source version 2026-11-12:781d56d001080bb2b28a76c2dc83199d39ad2d6c5fd82dd2cf86da79484ec9b7** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06632457) (`ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad-r2`)

### Correction lineage

updated on 2026-11-15: ClinicalTrials.gov posted a newer version of NCT06632457, with a registry update date of 2026-11-12. This version reports that observation; the earlier retained observation remains available as version 1.
- Supersedes version: 1
- Correction sources: [`ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad-r2`](#source-ctg-observation-nct06632457-2026-08-10-3a1f9c84b9ad-r2)

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06632457." Version 2, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct06632457-survodutide-v2 SHA-256: ad2f928cfdfb3b953dffbae67312dda58b9a51c4dc2c7f3b3ab9ea47b97f6991.

---

<a id="clinicaltrials-gov-nct07221591-survodutide-v1"></a>

## ClinicalTrials.gov record NCT07221591

> PeptideScanner retained ClinicalTrials.gov record NCT07221591 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-27, and PeptideScanner's reviewed identity mapping was survodutide.

- Evidence object: `story:clinicaltrials-gov-nct07221591-survodutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-10-27
- Source checked: 2026-11-14
- Published by PeptideScanner: 2026-11-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07221591-survodutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct07221591-survodutide-v1
- Content SHA-256: `8223592383c2a9db0e598aee227e0c5ab4a5c2ac359dc181ffb56efbea4e2fa9`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07221591 ([`ctg-observation-nct07221591-2026-10-27-34e2439f2404`](#source-ctg-observation-nct07221591-2026-10-27-34e2439f2404))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07221591 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-27, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct07221591-2026-10-27-34e2439f2404`](#source-ctg-observation-nct07221591-2026-10-27-34e2439f2404))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07221591 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-27, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct07221591-2026-10-27-34e2439f2404`](#source-ctg-observation-nct07221591-2026-10-27-34e2439f2404))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07221591-2026-10-27-34e2439f2404`](#source-ctg-observation-nct07221591-2026-10-27-34e2439f2404))

### Sources

<a id="source-ctg-observation-nct07221591-2026-10-27-34e2439f2404"></a>
- **ClinicalTrials.gov record NCT07221591 · retained source version 2026-10-27:34e2439f2404ec930104c1298f964eb4af2260776011cb1ffe5ae1d43ec2fe89** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07221591) (`ctg-observation-nct07221591-2026-10-27-34e2439f2404`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07221591." Version 1, published 2026-11-14. https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct07221591-survodutide-v1 SHA-256: 8223592383c2a9db0e598aee227e0c5ab4a5c2ac359dc181ffb56efbea4e2fa9.

---

<a id="clinicaltrials-gov-nct07413913-survodutide-v1"></a>

## ClinicalTrials.gov record NCT07413913

> PeptideScanner retained ClinicalTrials.gov record NCT07413913 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-15, and PeptideScanner's reviewed identity mapping was survodutide.

- Evidence object: `story:clinicaltrials-gov-nct07413913-survodutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-06-15
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07413913-survodutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct07413913-survodutide-v1
- Content SHA-256: `1521b20d3e7fe7f213131062d741d9d5aa45d6c3aaa9b624fab3f744671e00d9`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07413913 ([`ctg-observation-nct07413913-2026-06-15-fa294590fd7c`](#source-ctg-observation-nct07413913-2026-06-15-fa294590fd7c))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07413913 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-15, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct07413913-2026-06-15-fa294590fd7c`](#source-ctg-observation-nct07413913-2026-06-15-fa294590fd7c))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07413913 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-15, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct07413913-2026-06-15-fa294590fd7c`](#source-ctg-observation-nct07413913-2026-06-15-fa294590fd7c))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07413913-2026-06-15-fa294590fd7c`](#source-ctg-observation-nct07413913-2026-06-15-fa294590fd7c))

### Sources

<a id="source-ctg-observation-nct07413913-2026-06-15-fa294590fd7c"></a>
- **ClinicalTrials.gov record NCT07413913 · retained source version 2026-06-15:fa294590fd7cc5444998e4b0d3abdc41da89eb731e08e774b877bef3636e4883** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07413913) (`ctg-observation-nct07413913-2026-06-15-fa294590fd7c`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07413913." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct07413913-survodutide-v1 SHA-256: 1521b20d3e7fe7f213131062d741d9d5aa45d6c3aaa9b624fab3f744671e00d9.

---

<a id="clinicaltrials-gov-nct07754461-survodutide-v1"></a>

## ClinicalTrials.gov record NCT07754461

> PeptideScanner retained ClinicalTrials.gov record NCT07754461 at 2026-08-13T05:52:27.026Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was survodutide.

- Evidence object: `story:clinicaltrials-gov-nct07754461-survodutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-08-10
- Source checked: 2026-08-13
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07754461-survodutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct07754461-survodutide-v1
- Content SHA-256: `d64ba6f36b0048ea8ada119d4aa33fde8ad40801d183e24da0a5450cc6c8b15a`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07754461 ([`ctg-observation-nct07754461-2026-08-10-d71d6065261a`](#source-ctg-observation-nct07754461-2026-08-10-d71d6065261a))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07754461 at 2026-08-13T05:52:27.026Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct07754461-2026-08-10-d71d6065261a`](#source-ctg-observation-nct07754461-2026-08-10-d71d6065261a))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07754461 at 2026-08-13T05:52:27.026Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct07754461-2026-08-10-d71d6065261a`](#source-ctg-observation-nct07754461-2026-08-10-d71d6065261a))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07754461-2026-08-10-d71d6065261a`](#source-ctg-observation-nct07754461-2026-08-10-d71d6065261a))

### Sources

<a id="source-ctg-observation-nct07754461-2026-08-10-d71d6065261a"></a>
- **ClinicalTrials.gov record NCT07754461 · retained source version 2026-08-10:d71d6065261ae9f1c83fbc9694b2dc6cef63964c1377569876a214c0a75eb88e** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07754461) (`ctg-observation-nct07754461-2026-08-10-d71d6065261a`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07754461." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct07754461-survodutide-v1 SHA-256: d64ba6f36b0048ea8ada119d4aa33fde8ad40801d183e24da0a5450cc6c8b15a.

---

<a id="clinicaltrials-gov-nct07754461-survodutide-v2"></a>

## ClinicalTrials.gov record NCT07754461

> PeptideScanner retained ClinicalTrials.gov record NCT07754461 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was survodutide.

- Evidence object: `story:clinicaltrials-gov-nct07754461-survodutide:v2`
- Evidence domain: Clinical trials
- Date in source: 2026-11-13
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07754461-survodutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct07754461-survodutide-v2
- Content SHA-256: `85d3734e467564944adf70f7a5f03231e9f3400f57779ecbded6911b9bf00ff9`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07754461 ([`ctg-observation-nct07754461-2026-08-10-d71d6065261a-r2`](#source-ctg-observation-nct07754461-2026-08-10-d71d6065261a-r2))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07754461 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct07754461-2026-08-10-d71d6065261a-r2`](#source-ctg-observation-nct07754461-2026-08-10-d71d6065261a-r2))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07754461 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct07754461-2026-08-10-d71d6065261a-r2`](#source-ctg-observation-nct07754461-2026-08-10-d71d6065261a-r2))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07754461-2026-08-10-d71d6065261a-r2`](#source-ctg-observation-nct07754461-2026-08-10-d71d6065261a-r2))

### Sources

<a id="source-ctg-observation-nct07754461-2026-08-10-d71d6065261a-r2"></a>
- **ClinicalTrials.gov record NCT07754461 · retained source version 2026-11-13:52f3cdf0fe1efbb3df3f0dcf70b5317d3bb709d42a54d4dee104a97a73cf49b4** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07754461) (`ctg-observation-nct07754461-2026-08-10-d71d6065261a-r2`)

### Correction lineage

updated on 2026-11-15: ClinicalTrials.gov posted a newer version of NCT07754461, with a registry update date of 2026-11-13. This version reports that observation; the earlier retained observation remains available as version 1.
- Supersedes version: 1
- Correction sources: [`ctg-observation-nct07754461-2026-08-10-d71d6065261a-r2`](#source-ctg-observation-nct07754461-2026-08-10-d71d6065261a-r2)

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07754461." Version 2, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct07754461-survodutide-v2 SHA-256: 85d3734e467564944adf70f7a5f03231e9f3400f57779ecbded6911b9bf00ff9.

---

<a id="clinicaltrials-gov-nct07768813-survodutide-v1"></a>

## ClinicalTrials.gov record NCT07768813

> PeptideScanner retained ClinicalTrials.gov record NCT07768813 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-28, and PeptideScanner's reviewed identity mapping was survodutide.

- Evidence object: `story:clinicaltrials-gov-nct07768813-survodutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-10-28
- Source checked: 2026-11-14
- Published by PeptideScanner: 2026-11-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07768813-survodutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct07768813-survodutide-v1
- Content SHA-256: `6f22f1cd6b2f63795d39b99938fbdbb03d20b5598a77372cb09015ccdfdbc0b9`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07768813 ([`ctg-observation-nct07768813-2026-10-28-cbf46625b489`](#source-ctg-observation-nct07768813-2026-10-28-cbf46625b489))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07768813 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-28, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct07768813-2026-10-28-cbf46625b489`](#source-ctg-observation-nct07768813-2026-10-28-cbf46625b489))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07768813 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-28, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct07768813-2026-10-28-cbf46625b489`](#source-ctg-observation-nct07768813-2026-10-28-cbf46625b489))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07768813-2026-10-28-cbf46625b489`](#source-ctg-observation-nct07768813-2026-10-28-cbf46625b489))

### Sources

<a id="source-ctg-observation-nct07768813-2026-10-28-cbf46625b489"></a>
- **ClinicalTrials.gov record NCT07768813 · retained source version 2026-10-28:cbf46625b489bb900feef29d526ba25a4a2c24fcbdd6688d9f1af90a1e956105** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07768813) (`ctg-observation-nct07768813-2026-10-28-cbf46625b489`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07768813." Version 1, published 2026-11-14. https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct07768813-survodutide-v1 SHA-256: 6f22f1cd6b2f63795d39b99938fbdbb03d20b5598a77372cb09015ccdfdbc0b9.

---

<a id="clinicaltrials-gov-nct07850050-survodutide-v1"></a>

## ClinicalTrials.gov record NCT07850050

> PeptideScanner retained ClinicalTrials.gov record NCT07850050 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-30, and PeptideScanner's reviewed identity mapping was survodutide.

- Evidence object: `story:clinicaltrials-gov-nct07850050-survodutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-10-30
- Source checked: 2026-11-14
- Published by PeptideScanner: 2026-11-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07850050-survodutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct07850050-survodutide-v1
- Content SHA-256: `bbc11c6353ffb2397494ecfc65a0160e97a005da116920404c974ab8ab87c501`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07850050 ([`ctg-observation-nct07850050-2026-10-30-db4a0df466e0`](#source-ctg-observation-nct07850050-2026-10-30-db4a0df466e0))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07850050 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-30, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct07850050-2026-10-30-db4a0df466e0`](#source-ctg-observation-nct07850050-2026-10-30-db4a0df466e0))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07850050 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-30, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct07850050-2026-10-30-db4a0df466e0`](#source-ctg-observation-nct07850050-2026-10-30-db4a0df466e0))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07850050-2026-10-30-db4a0df466e0`](#source-ctg-observation-nct07850050-2026-10-30-db4a0df466e0))

### Sources

<a id="source-ctg-observation-nct07850050-2026-10-30-db4a0df466e0"></a>
- **ClinicalTrials.gov record NCT07850050 · retained source version 2026-10-30:db4a0df466e06bad29822d68f02fe12ecc36aaa8e3e4c2047881146b1a9d1934** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07850050) (`ctg-observation-nct07850050-2026-10-30-db4a0df466e0`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07850050." Version 1, published 2026-11-14. https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct07850050-survodutide-v1 SHA-256: bbc11c6353ffb2397494ecfc65a0160e97a005da116920404c974ab8ab87c501.

---

<a id="clinicaltrials-gov-nct07850063-survodutide-v1"></a>

## ClinicalTrials.gov record NCT07850063

> PeptideScanner retained ClinicalTrials.gov record NCT07850063 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was survodutide.

- Evidence object: `story:clinicaltrials-gov-nct07850063-survodutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-11-12
- Source checked: 2026-11-14
- Published by PeptideScanner: 2026-11-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07850063-survodutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct07850063-survodutide-v1
- Content SHA-256: `870971f350769c3f381aa9cd6b9321fe096dbcdd0660985792b4af4cb78568bb`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07850063 ([`ctg-observation-nct07850063-2026-11-12-c20f0dfb1e6b`](#source-ctg-observation-nct07850063-2026-11-12-c20f0dfb1e6b))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07850063 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct07850063-2026-11-12-c20f0dfb1e6b`](#source-ctg-observation-nct07850063-2026-11-12-c20f0dfb1e6b))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07850063 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct07850063-2026-11-12-c20f0dfb1e6b`](#source-ctg-observation-nct07850063-2026-11-12-c20f0dfb1e6b))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07850063-2026-11-12-c20f0dfb1e6b`](#source-ctg-observation-nct07850063-2026-11-12-c20f0dfb1e6b))

### Sources

<a id="source-ctg-observation-nct07850063-2026-11-12-c20f0dfb1e6b"></a>
- **ClinicalTrials.gov record NCT07850063 · retained source version 2026-11-12:c20f0dfb1e6ba7e498195b5045202fdc6b24f7722d7f726ca25502b41a3d9606** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07850063) (`ctg-observation-nct07850063-2026-11-12-c20f0dfb1e6b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07850063." Version 1, published 2026-11-14. https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct07850063-survodutide-v1 SHA-256: 870971f350769c3f381aa9cd6b9321fe096dbcdd0660985792b4af4cb78568bb.

---

<a id="clinicaltrials-gov-nct07855900-survodutide-v1"></a>

## ClinicalTrials.gov record NCT07855900

> PeptideScanner retained ClinicalTrials.gov record NCT07855900 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-27, and PeptideScanner's reviewed identity mapping was survodutide.

- Evidence object: `story:clinicaltrials-gov-nct07855900-survodutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-10-27
- Source checked: 2026-11-14
- Published by PeptideScanner: 2026-11-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07855900-survodutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct07855900-survodutide-v1
- Content SHA-256: `10d160e165ff70ca2c106c0f1c2181521a36a285b51eebb3cbf405fae9cdd78f`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07855900 ([`ctg-observation-nct07855900-2026-10-27-ca051fe13974`](#source-ctg-observation-nct07855900-2026-10-27-ca051fe13974))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07855900 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-27, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct07855900-2026-10-27-ca051fe13974`](#source-ctg-observation-nct07855900-2026-10-27-ca051fe13974))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07855900 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-27, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct07855900-2026-10-27-ca051fe13974`](#source-ctg-observation-nct07855900-2026-10-27-ca051fe13974))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07855900-2026-10-27-ca051fe13974`](#source-ctg-observation-nct07855900-2026-10-27-ca051fe13974))

### Sources

<a id="source-ctg-observation-nct07855900-2026-10-27-ca051fe13974"></a>
- **ClinicalTrials.gov record NCT07855900 · retained source version 2026-10-27:ca051fe13974d0df9ed1d7f9fed2169ca17d477b01915636c38c2d2b0103df2d** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07855900) (`ctg-observation-nct07855900-2026-10-27-ca051fe13974`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07855900." Version 1, published 2026-11-14. https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct07855900-survodutide-v1 SHA-256: 10d160e165ff70ca2c106c0f1c2181521a36a285b51eebb3cbf405fae9cdd78f.

---

<a id="clinicaltrials-gov-nct07940244-survodutide-v1"></a>

## ClinicalTrials.gov record NCT07940244

> PeptideScanner retained ClinicalTrials.gov record NCT07940244 at 2026-11-16T13:28:59.838Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was survodutide.

- Evidence object: `story:clinicaltrials-gov-nct07940244-survodutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-11-16
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07940244-survodutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct07940244-survodutide-v1
- Content SHA-256: `6832b259a85498fee5dfe0795a85e79ab35cd8b6277d4fee817950c4edac9f69`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07940244 ([`ctg-observation-nct07940244-2026-11-16-18074b6fd26d`](#source-ctg-observation-nct07940244-2026-11-16-18074b6fd26d))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07940244 at 2026-11-16T13:28:59.838Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct07940244-2026-11-16-18074b6fd26d`](#source-ctg-observation-nct07940244-2026-11-16-18074b6fd26d))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07940244 at 2026-11-16T13:28:59.838Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was survodutide. ([`ctg-observation-nct07940244-2026-11-16-18074b6fd26d`](#source-ctg-observation-nct07940244-2026-11-16-18074b6fd26d))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07940244-2026-11-16-18074b6fd26d`](#source-ctg-observation-nct07940244-2026-11-16-18074b6fd26d))

### Sources

<a id="source-ctg-observation-nct07940244-2026-11-16-18074b6fd26d"></a>
- **ClinicalTrials.gov record NCT07940244 · retained source version 2026-11-16:18074b6fd26d0ffe6e8199cecc01306a9b649bd51924b83bcd387820d52bba84** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07940244) (`ctg-observation-nct07940244-2026-11-16-18074b6fd26d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07940244." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/survodutide.json#clinicaltrials-gov-nct07940244-survodutide-v1 SHA-256: 6832b259a85498fee5dfe0795a85e79ab35cd8b6277d4fee817950c4edac9f69.

---

<a id="pubmed-pmid-40557206-survodutide-v1"></a>

## PubMed record PMID 40557206

> PeptideScanner retained PubMed bibliographic metadata for PMID 40557206 at 2026-07-30T18:26:54.791Z. PubMed recorded a metadata revision date of 2025-06-25 and an Entrez history date of 2025-06-25. PeptideScanner associated this retained record with the identity slug survodutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-40557206-survodutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-06-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40557206-survodutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/survodutide.json#pubmed-pmid-40557206-survodutide-v1
- Content SHA-256: `e37fe8e75082b9ec377c44789ebbde584d87cb437135d4f5e02426ebcac80c99`

### Claims and source pins

#### Headline

PubMed record PMID 40557206 ([`pubmed-observation-pmid-40557206-2025-06-25-b4dec1549583`](#source-pubmed-observation-pmid-40557206-2025-06-25-b4dec1549583))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 40557206 at 2026-07-30T18:26:54.791Z. PubMed recorded a metadata revision date of 2025-06-25 and an Entrez history date of 2025-06-25. PeptideScanner associated this retained record with the identity slug survodutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40557206-2025-06-25-b4dec1549583`](#source-pubmed-observation-pmid-40557206-2025-06-25-b4dec1549583))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 40557206 at 2026-07-30T18:26:54.791Z. PubMed recorded a metadata revision date of 2025-06-25 and an Entrez history date of 2025-06-25. PeptideScanner associated this retained record with the identity slug survodutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40557206-2025-06-25-b4dec1549583`](#source-pubmed-observation-pmid-40557206-2025-06-25-b4dec1549583))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40557206-2025-06-25-b4dec1549583`](#source-pubmed-observation-pmid-40557206-2025-06-25-b4dec1549583))

### Sources

<a id="source-pubmed-observation-pmid-40557206-2025-06-25-b4dec1549583"></a>
- **PubMed record PMID 40557206 · retained source version 1:2025-06-25:current:b4dec1549583bd000a131e98544adcaf1ce4b838bd0451e3c6792c8df0a32606** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40557206/) (`pubmed-observation-pmid-40557206-2025-06-25-b4dec1549583`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 40557206." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/survodutide.json#pubmed-pmid-40557206-survodutide-v1 SHA-256: e37fe8e75082b9ec377c44789ebbde584d87cb437135d4f5e02426ebcac80c99.

---

<a id="pubmed-pmid-41388343-survodutide-v1"></a>

## PubMed record PMID 41388343

> PeptideScanner retained PubMed bibliographic metadata for PMID 41388343 at 2026-07-30T16:25:14.127Z. PubMed recorded a metadata revision date of 2026-02-14 and an Entrez history date of 2025-12-13. PeptideScanner associated this retained record with the identity slug survodutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41388343-survodutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-02-14
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41388343-survodutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/survodutide.json#pubmed-pmid-41388343-survodutide-v1
- Content SHA-256: `5ff83a80412405d9d7714e16f7e489e100dcc135207830665480c382d27974b5`

### Claims and source pins

#### Headline

PubMed record PMID 41388343 ([`pubmed-observation-pmid-41388343-2026-02-14-e2cc969b737d`](#source-pubmed-observation-pmid-41388343-2026-02-14-e2cc969b737d))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41388343 at 2026-07-30T16:25:14.127Z. PubMed recorded a metadata revision date of 2026-02-14 and an Entrez history date of 2025-12-13. PeptideScanner associated this retained record with the identity slug survodutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41388343-2026-02-14-e2cc969b737d`](#source-pubmed-observation-pmid-41388343-2026-02-14-e2cc969b737d))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41388343 at 2026-07-30T16:25:14.127Z. PubMed recorded a metadata revision date of 2026-02-14 and an Entrez history date of 2025-12-13. PeptideScanner associated this retained record with the identity slug survodutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41388343-2026-02-14-e2cc969b737d`](#source-pubmed-observation-pmid-41388343-2026-02-14-e2cc969b737d))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41388343-2026-02-14-e2cc969b737d`](#source-pubmed-observation-pmid-41388343-2026-02-14-e2cc969b737d))

### Sources

<a id="source-pubmed-observation-pmid-41388343-2026-02-14-e2cc969b737d"></a>
- **PubMed record PMID 41388343 · retained source version 1:2026-02-14:current:e2cc969b737d35d73bbd5d26c84bf97d2de17a378e88d07d4486e9b382f24012** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41388343/) (`pubmed-observation-pmid-41388343-2026-02-14-e2cc969b737d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41388343." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/survodutide.json#pubmed-pmid-41388343-survodutide-v1 SHA-256: 5ff83a80412405d9d7714e16f7e489e100dcc135207830665480c382d27974b5.

---

<a id="pubmed-pmid-41424209-survodutide-v1"></a>

## PubMed record PMID 41424209

> PeptideScanner retained PubMed bibliographic metadata for PMID 41424209 at 2026-07-30T16:25:14.150Z. PubMed recorded a metadata revision date of 2026-02-10 and an Entrez history date of 2025-12-22. PeptideScanner associated this retained record with the identity slug survodutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41424209-survodutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-02-10
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41424209-survodutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/survodutide.json#pubmed-pmid-41424209-survodutide-v1
- Content SHA-256: `ef2b91424a6327bbdcb87667a007d885286ad0362844b1d3e100703a309b9dbd`

### Claims and source pins

#### Headline

PubMed record PMID 41424209 ([`pubmed-observation-pmid-41424209-2026-02-10-13ace056ff0c`](#source-pubmed-observation-pmid-41424209-2026-02-10-13ace056ff0c))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41424209 at 2026-07-30T16:25:14.150Z. PubMed recorded a metadata revision date of 2026-02-10 and an Entrez history date of 2025-12-22. PeptideScanner associated this retained record with the identity slug survodutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41424209-2026-02-10-13ace056ff0c`](#source-pubmed-observation-pmid-41424209-2026-02-10-13ace056ff0c))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41424209 at 2026-07-30T16:25:14.150Z. PubMed recorded a metadata revision date of 2026-02-10 and an Entrez history date of 2025-12-22. PeptideScanner associated this retained record with the identity slug survodutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41424209-2026-02-10-13ace056ff0c`](#source-pubmed-observation-pmid-41424209-2026-02-10-13ace056ff0c))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41424209-2026-02-10-13ace056ff0c`](#source-pubmed-observation-pmid-41424209-2026-02-10-13ace056ff0c))

### Sources

<a id="source-pubmed-observation-pmid-41424209-2026-02-10-13ace056ff0c"></a>
- **PubMed record PMID 41424209 · retained source version 1:2026-02-10:current:13ace056ff0c221708cab0f8d326324a56d407b1eb5d9fa2a420f60fe7c59462** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41424209/) (`pubmed-observation-pmid-41424209-2026-02-10-13ace056ff0c`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41424209." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/survodutide.json#pubmed-pmid-41424209-survodutide-v1 SHA-256: ef2b91424a6327bbdcb87667a007d885286ad0362844b1d3e100703a309b9dbd.

---

<a id="pubmed-pmid-42897119-survodutide-v1"></a>

## Interpreting Survodutide Renoprotection in a Hyperfiltration Model.

> PubMed lists PMID 42897119 in Diabetes, obesity & metabolism as Letter, with publication-date metadata of 2026-10-19 (day precision). PeptideScanner associated the retained record with the identity slug survodutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42897119-survodutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-10-19
- Source checked: 2026-11-14
- Published by PeptideScanner: 2026-11-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42897119-survodutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/survodutide.json#pubmed-pmid-42897119-survodutide-v1
- Content SHA-256: `1c78f5aaf813c03bdf2b160911aa9864c124d5a3d433353cb33eb4717661754c`

### Claims and source pins

#### Headline

Interpreting Survodutide Renoprotection in a Hyperfiltration Model. ([`pubmed-observation-pmid-42897119-2026-10-19-6d399938aaae`](#source-pubmed-observation-pmid-42897119-2026-10-19-6d399938aaae))

#### Summary

PubMed lists PMID 42897119 in Diabetes, obesity & metabolism as Letter, with publication-date metadata of 2026-10-19 (day precision). PeptideScanner associated the retained record with the identity slug survodutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42897119-2026-10-19-6d399938aaae`](#source-pubmed-observation-pmid-42897119-2026-10-19-6d399938aaae))

#### Paragraph 1

PubMed lists PMID 42897119 in Diabetes, obesity & metabolism as Letter, with publication-date metadata of 2026-10-19 (day precision). PeptideScanner associated the retained record with the identity slug survodutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42897119-2026-10-19-6d399938aaae`](#source-pubmed-observation-pmid-42897119-2026-10-19-6d399938aaae))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42897119-2026-10-19-6d399938aaae`](#source-pubmed-observation-pmid-42897119-2026-10-19-6d399938aaae))

### Sources

<a id="source-pubmed-observation-pmid-42897119-2026-10-19-6d399938aaae"></a>
- **Interpreting Survodutide Renoprotection in a Hyperfiltration Model. · retained source version 1:2026-10-19:current:6d399938aaae9700752344d0ffc642c4bc73512db21eb3da1f670ac9651fb7d1** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42897119/) (`pubmed-observation-pmid-42897119-2026-10-19-6d399938aaae`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Interpreting Survodutide Renoprotection in a Hyperfiltration Model." Version 1, published 2026-11-14. https://peptidescanner.com/evidence/v1/peptides/survodutide.json#pubmed-pmid-42897119-survodutide-v1 SHA-256: 1c78f5aaf813c03bdf2b160911aa9864c124d5a3d433353cb33eb4717661754c.

---

<a id="survodutide-liver-activity-study-updated-v1"></a>

## Survodutide liver-activity study record updated

> ClinicalTrials.gov lists an active, not recruiting Survodutide study sponsored by Boehringer Ingelheim.

- Evidence object: `story:survodutide-liver-activity-study-updated:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-22
- Source checked: 2026-07-22
- Published by PeptideScanner: 2026-07-22
- Story landing page: https://peptidescanner.com/stories/survodutide-liver-activity-study-updated/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/survodutide.json#survodutide-liver-activity-study-updated-v1
- Content SHA-256: `eb3eb3de1be039a6be55c9e71f9abd624a4fa698d1a6be5c4d269bccf1c69318`

### Claims and source pins

#### Headline

Survodutide liver-activity study record updated ([`ctg-nct05202353-v50`](#source-ctg-nct05202353-v50))

#### Summary

ClinicalTrials.gov lists an active, not recruiting Survodutide study sponsored by Boehringer Ingelheim. ([`ctg-nct05202353-v50`](#source-ctg-nct05202353-v50))

#### Paragraph 1

ClinicalTrials.gov lists the NCT05202353 record under Boehringer Ingelheim. Its overall recruitment status was shown as active, not recruiting when PeptideScanner reviewed the record. ([`ctg-nct05202353-v50`](#source-ctg-nct05202353-v50))

#### Paragraph 2

The registry shows 2026-07-22 as its latest posted update date. This update reports the registry record and does not establish safety, effectiveness, or a trial outcome. ([`ctg-nct05202353-v50`](#source-ctg-nct05202353-v50))

### Sources

<a id="source-ctg-nct05202353-v50"></a>
- **BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver · record history version 50 · last update posted 2026-07-22** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05202353?a=50&tab=history) (`ctg-nct05202353-v50`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Survodutide liver-activity study record updated." Version 1, published 2026-07-22. https://peptidescanner.com/evidence/v1/peptides/survodutide.json#survodutide-liver-activity-study-updated-v1 SHA-256: eb3eb3de1be039a6be55c9e71f9abd624a4fa698d1a6be5c4d269bccf1c69318.

